Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
September 30, 2026 335.06M
June 30, 2026 228.92M
March 31, 2026 84.36M
December 31, 2025 93.80M
September 30, 2025 8.265M
June 30, 2025 4.653M
March 31, 2025 9.594M
December 31, 2024 13.25M
September 30, 2024 17.55M
June 30, 2024 23.89M
March 31, 2024 27.92M
Date Value
December 31, 2023 16.41M
September 30, 2023 19.77M
June 30, 2023 13.23M
March 31, 2023 11.77M
December 31, 2022 13.16M
September 30, 2022 16.75M
June 30, 2022 18.11M
March 31, 2022 19.65M
December 31, 2021 17.99M
September 30, 2021 -6.196M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.387B
Alnylam Pharmaceuticals, Inc. 3.604B
Anika Therapeutics, Inc. 137.58M
Savara, Inc. 107.85M
Arrowhead Pharmaceuticals, Inc. 50.31M

Shareholders Equity (Quarterly) Related Metrics